Publications That Use U.S. Cancer Statistics Data

Background

Researchers, cancer registry staff, and others use U.S. Cancer Statistics data to advance scientific knowledge and reduce cancer. Stat Bites, data briefs, and a selection of peer-reviewed journal articles that use U.S. Cancer Statistics data are highlighted below.

Stat Bites

5 older people of various ethnicities outdoors
U.S. Cancer Statistics Lung Cancer Stat Bite
In the U.S. in 2021, 209,500 new lung cancers were reported.
4 people of diverse ethnicities jogging outdoors
U.S. Cancer Statistics Colorectal Cancer Stat Bite
In the United States in 2021, 141,902 new colorectal cancers were reported.
An older man and his adult son
U.S. Cancer Statistics Prostate Cancer Stat Bite
In the United States in 2021, 236,659 new prostate cancers were reported.
3 women sitting on a yoga mat
U.S. Cancer Statistics Breast Cancer Stat Bite
In the United States in 2021, 272,454 new breast cancers were reported in females.

Data briefs

Prostate Cancer Incidence by Stage at Diagnosis
In 2021, 236,659 new cases of prostate cancer were reported in the United States.
Types of lung cancer
More lung cancers are being found at an early stage when they are more treatable.
Metastatic Female Breast Cancer Incidence
The incidence of metastatic female breast cancer increased from 2001 to 2021.
Incidence of Malignant Mesothelioma
Mesothelioma is a cancer that forms in the tissue that lines many internal organs.
Cancers Associated with Human Papillomavirus
About 48,000 HPV-associated cancers occurred in the United States each year from 2017 to 2021.
Highlights from 2021 Cancer Incidence with Comparisons to Previous Years
U.S. Cancer Statistics includes 1,777,566 new cases of invasive cancer occurring in 2021.

Selected journal articles

2024

  • Campbell K, Siegel DA, Umaretiya PJ, et al. Pediatr Blood Cancer. 2024;71(1):e30732.
  • Gopalani SV, Senkomago V, Rim SH, Saraiya M. J Natl Cancer Inst. 2024;116(2):275–282.

2023

  • Holman DM, King JB, White A, Singh SD, Lichtenfeld JL. Prev Med. 2023:175:107692.
  • Siegel DA, King JB, Lupo PJ, et al. J Natl Cancer Inst. 2023;115(11):1337–1354.

2022

  • Chang SH, Patel N, Du M, Liang PS. Clin Gastroenterol Hepatol. 2022;20(6):e1365–e1377.
  • Cho MY, Siegel DA, Demb J, Richardson LC, Gupta S. Dig Dis Sci. 2022;67(8):4086–4091.
  • Ellington TD, Miller JW, Henley SJ, Wilson RJ, Wu, M, Richardson LC. MMWR Morb Mortal Wkly Rep. 2022;71(2):43.
  • Liao CI, Francoeur AA, Kapp DS, Caesar MAP, Huh WK, Chan JK. JAMA Netw Open. 2022;5(3):e222530.
  • Melkonian SC, Jim MA, Pete D, et al. Cancer. 2022;128(8):1626–1636.
  • Minihan AK, Patel AV, Flanders WD, Goding Sauer A, Jemal A, Islami F. Med Sci Sports Exerc. 2022;54(3):417–423.
  • Raza SA, da Costa WL, Thrift AP. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1410–1417.
  • Shah RR, Millien VO, da Costa WL, Oluyomi AO, Gould Suarez M, Thrift AP. Cancer. 2022;128(2):299–310.

2021

  • Bartley SJ, Wu M, Benard V, Ambrosone C, Richardson LC. J Natl Med Assoc. 2021;113(3):353–356.
  • Culp MB, Benard V, Dowling NF, et al. Eye (Lond). 2021;35(2):687–689.
  • Ellington TD, Henley SJ, Wilson RJ, Wu M, Richardson LC. Cancer Med. 2021;10(1):386–395.
  • Mix JM, Van Dyne EA, Saraiya M, Hallowell BD, Thomas CC. Cancer Epidemiol Biomarkers Prev. 2021;30(1):30–37.
  • Turbow SD, White MC, Breslau ES, Sabatino SA. Breast Cancer Res Treat. 2021;188(1):307–316.

2020

  • Ellington TD, Henley SJ, Senkomago V, et al. MMWR Morb Mortal Wkly Rep. 2020;69:433–438.
  • Ellington TD, Henley SJ, Wilson RJ, Miller JW. MMWR Morb Mortal Wkly Rep. 2020;69(41):1481–1484.
  • Henley SJ, Peipins LA, Rim SH, Larson TC, Miller JW. J Womens Health (Larchmt). 2020;29(1):111–118.
  • Iyengar S, Hall IJ, Sabatino SA. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1357–1364.
  • Siegel DA, O'Neil ME, Richards TB, Dowling NF, Weir HK. MMWR Morb Mortal Wkly Rep. 2020;69:1473–1480.
Print
Content Source:
National Center for Chronic Disease Prevention and Health Promotion; Division of Cancer Prevention and Control